**Core Concept**
Warfarin and other vitamin K antagonists are oral anticoagulants that exert their effect by inhibiting the production of vitamin K-dependent clotting factors in the liver. These agents are commonly used to prevent thromboembolic events in patients with atrial fibrillation, deep vein thrombosis, and prosthetic heart valves.

**Why the Correct Answer is Right**
The correct answer is Dabigatran. Dabigatran is a direct oral anticoagulant (DOAC) that selectively inhibits thrombin, the final common pathway in the coagulation cascade. It is administered orally and has a half-life of approximately 12-17 hours, but its effect can last up to 2-3 days due to its active metabolite. This makes it one of the longest-acting oral anticoagulants available.

**Why Each Wrong Option is Incorrect**
**Option A:** Warfarin is a vitamin K antagonist with a half-life of 20-60 hours, but its effect is more variable and can be reversed with vitamin K administration.

**Option B:** Rivaroxaban is another DOAC that inhibits Factor Xa, but it has a half-life of 7-11 hours and is not as long-acting as dabigatran.

**Option C:** Apixaban is also a Factor Xa inhibitor with a half-life of 8-15 hours, similar to rivaroxaban and not as long-acting as dabigatran.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that DOACs like dabigatran do not require regular monitoring of INR levels, unlike warfarin, which makes them more convenient for patients with limited access to laboratory facilities.

**Correct Answer:** D. Dabigatran.